Quick question: how did you learn to code? It probably wasn’t bribing someone a year or two ahead of you in CS to finish all ...

OpenAI just unveiled a brand new image generator that it claims can churn out smarter and more precise slop than ever before. ChatGPT Images 2.0 is going to be a “renaissance” in AI image generation, ...

Each round in Buckshot Roulette, you'll receive a handful of items to help turn the odds in your favor. Some are used to inconvenience the dealer, and others will help keep you in the game after a bad ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Forbes contributors publish independent expert analyses and insights. I write about innovation, the future of work and remote work. The future of programming and AI is more nuanced than headlines ...

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling. And no, in case you were wondering, python is not a snake in ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...